- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Drug firm
Pfizer's Managing Director S Sridhar Resigns
Over the past six years, he has led Pfizer as Managing Director and made significant contributions to the growth of the company's portfolio and presence across India, the drug firm stated
Read More
Zydus Cadila Gets USFDA Approval To Market Generic Schizophrenia Drug
The drug production will be done at the group's formulation manufacturing facility in the Special Economic Zone (SEZ), Ahmedabad.
Read More
Cadila Healthcare Gets DCGI Nod To Conduct Phase III Trials For Two-Dose COVID Vaccine
Shares of Cadila Healthcare Ltd were trading at Rs 563.95 per scrip on BSE, up 0.29 percent from their previous close
Read More
Eli Lilly To Transfer Rights Of Two Diabetes Products To Cipla
The Gurgaon-based firm, which is a wholly-owned subsidiary of US-based Eli Lilly and Company, has inked a pact with Cipla in this regard.
Read More
Zydus Cadila Gets USFDA Nod To Market Depression Treatment Drug In US Market
The drug will be manufactured at the group''s formulation manufacturing facility at the SEZ, Ahmedabad, Zydus Cadila noted.
Read More
Dr Reddy''s Launches Minoxidil For Treatment Of Female Pattern Hair Loss In India
The launch follows the first-ever approval of the additional indication by the Central Drugs Standard Control Organisation (COSCO) in India for the use of the product for the treatment of female pattern hair loss (FPHL)
Read More
Panacea Biotec Supplies Second Component Of Sputnik V Vaccine In India
Sputnik V has pioneered the use of heterogeneous boosting (two different vectors for the two shots in a course of vaccination among COVID vaccines).
Read More
Lupin Launches Pressurised Metered Dose Inhaler In UK
Shares of Lupin Ltd on Tuesday closed at Rs 940.90 per scrip on the BSE, up 1.75 per cent from its previous close.
Read More
Astrazeneca Pharma India Q1 Net Profit Declines 45 % To Rs 10.24 Cr
Revenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago
Read More
Abbott India Q1 Net Profit Up 8.5 % To Rs 195.76 Cr
Shares of Abbott India were trading at Rs 17,666.10 per scrip on BSE, down 1.51 per cent from its previous close.
Read More
Glenmark Inks Deal With Sanotize For COVID Treatment Spray In India, Other Asian Mkts
SaNOtize developed and patented a Nitric Oxide Releasing Solution platform technology (NORSTM) to treat and prevent microbial infections in 2017.
Read More
Lupin To Acquire Australia-Based Southern Cross Pharma
This will significantly increase Lupin's value proposition and market share in the Australian market
Read More
Alkem Laboratories Says USFDA Inspection At Taloja Facility Ends With 'Zero' Observations
Shares of Alkem Laboratories were trading 0.30 per cent lower at Rs 3,362.05 apiece on BSE.
Read More
Torrent Pharma Q1 Net Profit Up 2.8 % To Rs 330 Cr
Consolidated revenue from operations of the company stood at Rs 2,134 crore for the quarter under consideration. It was Rs 2,056 crore for the same period a year ago
Read More
Sanofi India Reports Q2 Net Profit At Rs 178.3 Cr
Revenue from operations of the company stood at Rs 789.1 crore for the quarter under consideration. It was Rs 710.5 crore for the same period a year ago
Read More